Press Release Virtus Investment Partners Announces Financial Results for First Quarter 2024 26 April 2024
Press Release Phillips 66 Reports 1Q 2024 Financial Results, Highlights Strategic Priorities Progress 26 April 2024
Press Release Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2024 and Raises Full Year Guidance 26 April 2024
Press Release U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B 26 April 2024
